Companies /Healthcare

Steris Plc

NYSE: STE Medical Devices
$254.79
▼ $4.78 (−1.84%) today
Markets closed · 4:57pm ET

24/7 Wall St. View

STE at a Glance

Valuation
Market cap
$25.2B
P/E ratio
30.8
Dividend yield
1.00%
Profitability
Revenue (TTM)
$6.2B
Profit margin
13.4%
EPS (TTM)
$8.43
Price
52-week range
$193 – $267
24/7 target
$303.40
Street target
$281.14
Earnings
Next report
Feb 2, 2027

Headquartered in Mentor, OH Fiscal year ends March NYSE: STE steris.com

About Steris

STERIS plc provides products and services that support patient care, with an emphasis on infection prevention, for hospitals, medical device makers and pharmaceutical and research customers. It reports three segments.

- **Healthcare:** the largest segment. It sells consumables, service and capital equipment for sterile processing, surgical and procedural settings.
- **Applied Sterilization Technologies (AST):** provides contract sterilization services to medical device and pharmaceutical manufacturers, plus a small amount of capital equipment.
- **Life Sciences:** supplies consumables, service and capital equipment to biopharmaceutical and research customers.

Recurring consumables and service revenue makes up the large majority of sales. The United States accounts for about 74% of revenue. The company is pursuing the acquisition of Xodus Medical, Inc., and is executing restructuring and facility consolidation plans, including a new Center of Excellence in North Carolina. Updated

Latest Activity

STESteris
Q2 2027
EPS
$2.94
est $2.68+9.8%
Revenue
$1.59B
est $1.56B+1.8%

Life Sciences capital equipment revenue jumped 53%, pushing management to raise full-year adjusted EPS guidance to $11.35-$11.55. Tariff refunds contribute about $0.18 of that, trimming the size of the underlying raise.

Quarterly EPS — reported vs estimate

STE Coverage

Frequently Asked Questions

What does Steris do?

STERIS plc provides products and services that support patient care, with an emphasis on infection prevention, for hospitals, medical device makers and pharmaceutical and research customers. It reports three segments. - **Healthcare:** the largest segment.

What is the STE stock price target?

24/7 Wall St.'s 12-month price target for STE is $303.40, rated Buy. The Wall Street consensus target is $281.14. STE price prediction →